ADHD Clinical Trial - School-Home Program for Mexican Children With

Status Completed

Clinical Trial Summary

Clinical Trial Description

A school-based behavioral intervention for Mexican youth with attention/behavior concerns (the Collaborative Life Skills Program for Latinos/Familias Unidades Empezando Retos y Tareas para el Éxito [CLS-FUERTE]:) will be pilot-tested in a mixed-method investigation with four Mexican elementary schools. Participants will include 24-32 students (n = 6-8 per 4 schools) in participating schools. School personnel will help identify students with and at-risk for Attention-Deficit/Hyperactivity Disorder (ADHD) with at least one caretaker and teacher able to participate in the intervention. Students must be in 1st-6th grade at a participating school and must demonstrate clinically significant attention/behavioral concerns and related impairment as rated by caretakers and teachers. Caretakers and teachers must be able to attend program sessions held at the child's school over an approximately 6-week period. Through a school-clustered random assignment design, two schools will be selected to receive CLS-FUERTE during the fall of the 2016-2017 school year and two schools will be selected to receive school services as usual while waiting to receive CLS-FUERTE the spring of the 2016-2017 school year. Caregivers and teachers of students will complete questionnaires about child behavior and family functioning and caregivers will participate in focus groups at 4 time points regardless of treatment assignment: Pre (prior to random assignment), Post 1 (following CLS-FUERTE in the fall cohort), Post 2 (following CLS-FUERTE for in spring cohort), and Follow-up (at the end of the school year). Feasibility and acceptability of CLS-FUERTE will be examined via participation enrollment, attendance, and engagement ratings and focus group feedback. Improvement in satisfaction with school services and youth outcomes will be examined and estimates of effect sizes will be used to support future scaled-up investigation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02888821
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Completed
Phase	N/A
Start date	August 2016
Completion date	July 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03148782` - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase	N/A
Recruiting	`NCT06038942` - Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress	N/A
Not yet recruiting	`NCT06456372` - Digital Health Intervention for Children With ADHD	N/A
Completed	`NCT05518435` - Managing Young People With ADHD in Primary Care Study
Active, not recruiting	`NCT04978792` - Does Cultivating Self-compassion Improve Resilience to Criticism and Improve Mental Health in Adults With ADHD?	N/A
Completed	`NCT03216512` - Effects of Noise Cancelling Headphones on Neurocognitive and Academic Outcomes in ADHD	N/A
Completed	`NCT02900144` - Modified Comprehensive Behavioral Intervention for Tics (M_CBIT)	N/A
Not yet recruiting	`NCT02906501` - Effect of Risperidone on Cognitive Functions in Adolescents With ADHD and Behavioral Disturbances	N/A
Completed	`NCT02829528` - Little Flower Yoga for Kids: Evaluation of a Yoga and Mindfulness Program for Children With Increased Levels of Emotion Dysregulation and Inattention	N/A
Completed	`NCT02562469` - ACTIVATE: A Computerized Training Program for Children With ADHD	N/A
Terminated	`NCT02271880` - Improving Medication Adherence in ADHD Adolescents	N/A
Recruiting	`NCT02255565` - Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Pilot Study	Phase 4
Completed	`NCT02463396` - Mindfulness Training in Adults With ADHD	N/A
Completed	`NCT01673594` - Prevention of Stimulant-Induced Euphoria With an Opioid Receptor Antagonist	Phase 4
Terminated	`NCT01733680` - Amiloride Hydrochloride as an Effective Treatment for ADHD	Early Phase 1
Completed	`NCT02300597` - Internet-based Support for Young People With ADHD and Autism - a Controlled Study	N/A
Active, not recruiting	`NCT01137318` - Combined Cognitive Remediation and Behavioral Intervention for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)	Phase 2
Completed	`NCT01404273` - Functional MRI of Relaxation Response Training in Adults With Attention-Deficit/Hyperactivity Disorder	N/A
Completed	`NCT00586157` - Study of Medication Patch to Treat Children Ages 6-12 With ADHD	Phase 4
Completed	`NCT00573859` - The Reinforcing Mechanisms of Smoking in Adult ADHD	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

School-Home Program for Mexican Children With Attention and Behavioral Concerns — CLS-FUERTE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms